REDWOOD SHORES, CA — (Marketwire) — 10/18/12 — Oracle Corporation (NASDAQ: ORCL) today announced the pricing of its sale of $2.5 billion of 1.200% Notes due 2017 (the “2017 Notes”) and $2.5 billion of 2.500% Notes due 2022 (the “2022 Notes”). The offering is expected to settle on October 25, 2012.
The 2017 Notes will bear interest at the rate of 1.200% per year and the 2022 Notes will bear interest at the rate of 2.500% per year. Interest will be payable semi-annually on April 15 and October 15 for each of the 2017 Notes and the 2022 Notes, commencing on April 15, 2013.
Oracle intends to use the net proceeds from the offering for general corporate purposes, which may include stock repurchases, future acquisitions and repayment of indebtedness, including repayment of its 4.95% senior notes due April 2013.
The offering is being made through an underwriting syndicate led by Citigroup Global Markets Inc., J.P. Morgan Securities LLC, RBS Securities Inc. and Wells Fargo Securities, LLC.
The offering of these securities is made only by means of a prospectus, copies of which may be obtained by contacting: Citigroup Global Markets Inc., c/o Broadbridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Telephone: (800) 831-9146, Email: ; J.P. Morgan Securities LLC, Attention: Investment Grade Syndicate Desk, 383 Madison Avenue, 3rd Floor, New York, NY 10179, Telephone: (212) 834-4533; RBS Securities Inc., 600 Washington Boulevard, Stamford, CT 06901, Telephone: (866) 884-2071; or Wells Fargo Securities, LLC, 1525 West W.T. Harris Blvd., NC0675, Charlotte, NC 28262, Attention: Capital Markets Client Support, Telephone: (800) 326-5897, Email: .
The notes are being offered pursuant to an automatically effective shelf registration statement filed with the Securities and Exchange Commission on May 7, 2010.
This press release does not constitute an offer to sell or the solicitation of an offer to buy securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.
Contact:
Ken Bond
Oracle Investor Relations
+1.650.607.0349
Deborah Hellinger
Oracle Corporate Communications
+1.212.508.7935
You must be logged in to post a comment Login